Übersetzung für "Type II extreme value distribution " (Englisch → Französisch) :

(i) varying Part XIII or Part XVI by prescribing additional disclosure requirements in respect of investment funds and requiring or permitting the use of particular forms or types of additional offering or other documents in connection with the funds, (ii) prescribing permitted investment policy and investment practices for investment funds and prohibiting or restricting certain investments or investment practices for investment funds, (iii) prescribing requirements governing the custodianship of assets of investment funds, (iv) presc ...[+++]ribing minimum initial capital requirements for investment funds making a distribution and prohibiting or restricting the reimbursement of costs in connection with the organization of a fund, (v) prescribing matters affecting investment funds that require the approval of security holders of the fund, the Commission or the Director, including, in the case of security holders, the level of approval, (vi) prescribing requirements in respect of the calculation of the net asset value of investment funds, (vii) prescribing requirements in respect of the content and use of sales literature, sales communications or advertising relating to investment funds or the securities of investment funds,

Question No. 75 Mr. Paul Dewar: With regard to the Technology Partnerships Canada (TPC) and Strategic Aerospace and Defence Initiative (SADI) programs of Industry Canada: (a) how many new jobs are estimated to have been created as a result of each program, broken down into direct and indirect results; (b) how many new jobs are estimated to have been produced in the TPC program areas of (i) environmental technologies, (ii) enabling technologies, (iii) aerospace and defence; (c) how many previously existing jobs are estimated to have been maintained as a result of each program, broken down into direct and indirect results; (d) how many ...[+++]previously existing jobs are estimated to have been maintained in the TPC program areas of (i) environmental technologies, (ii) enabling technologies, (iii) aerospace and defence; (e) which ten projects created the most jobs per government dollar disbursed through each program and how many new jobs did each of these projects produce; (f) which ten projects maintained the most jobs per government dollar disbursed through each program and how many jobs did each of these projects maintain; (g) which ten projects created the fewest jobs per government dollar disbursed through each program and how many new jobs did each of these projects create; (h) which ten projects maintained the fewest jobs per government dollar disbursed through each program and how many jobs did each of these projects maintain; (i) how many TPC projects were approved in fiscal year 2006-2007; (j) how many SADI projects, with what total disbursement value, have been approved in each fiscal year from 2007-2013; (k) what percentage of SADI-funded projects are subject to conditional repayment based on gross business revenues; (l) what percentage of the total disbursements made through SADI are subject to conditional repayment based on gross business revenues and what is the dollar value of this subset of total disbursements; (m) how many SADI-funded projects ha ...

Such information shall include (if relevant to the specific type of securitisation and not limited to such types of information further described herein), the exposure type, the percentage of loans more than 30, 60 and 90 days past due, default rates, prepayment rates, loans in foreclosure, collateral type and occupancy, frequency distribution of credit scores or other measures of credit worthiness across underlying exposures, industry and geographical diversification and frequency distribution of loan to ...[+++]value ratios with bandwidths that facilitate adequate sensitivity analysis.

(Return tabled) Question No. 849 Hon. Stéphane Dion: With regard to the Joint Strike Fighter (JSF) program, since the beginning of Canada's participation: (a) what are the criteria (operational requirements, contractual conditions, etc) on which the government is selecting the F-35s as a replacement for the CF-18s; (b) when and by whom were those criteria determined; (c) what are the relevant studies which were conducted prior to determining those criteria, specifying the (i) dates, (ii) names of the studies, (iii) names of individuals requesting the studies, (iv) authors of the studies, (v) names of the individuals presented with the ...[+++]results; (d) before those criteria were determined, on the basis of what information did the government evaluate that the F-35 could satisfy Canada's needs; (e) since the beginning of Canada's participation in the JSF program, what were all the studies conducted that evaluated different fighter planes in relation to Canada's needs, specifying the (i) dates, (ii) names of the studies, (iii) names of individuals requesting the studies, (iv) authors of the studies, (v) studies which were used to evaluate the planes, (vi) names of the individuals who determined those criteria, (vii) planes which were considered in the study, (viii) names of the individuals presented with the results; (f) what is the operational availability of a fleet of 65 fighter jets; (g) what effect will a reduction in Canada's fleet of fighter jets have on operational capability, on Canada's ability to play its role within the North American Aerospace Defence Command (NORAD) and on the distribution of fighter jets across Canada's military bases; (h) how did the government determine that Canadian Forces needed 65 planes; (i) what is the formula used to determine the number of planes Canada should buy and who is the author of that formula; (j) for each of the variables in that formula, how was the value of that variable determined, specifying by whom, based on ...

Where relevant, this shall include the exposure type, the percentage of loans more than 30, 60 and 90 days past due, default rates, prepayment rates, loans in foreclosure, collateral type and occupancy, and frequency distribution of credit scores or other measures of credit worthiness across underlying exposures, industry and geographical diversification, frequency distribution of loan to value ratios with band widths that facilita ...[+++]te adequate sensitivity analysis.

Question No. 138 Hon. John McKay: With respect to Canadians with diabetes who suffer severe and life-threatening adverse reactions to synthetic insulin and are unable to obtain domestically, an alternative animal-based insulin: (a) what actions has Health Canada taken or will take to ensure that Canadians who require such medication will continue to have access to it; (b) is the government (i) investigating methods of producing the medication via public funds or public-private partnership, (ii) initiating a process seeking approval of the drug for domestic production and distribution ...[+++], (iii) initiating a consultation process with the manufacturers of animal insulin seeking domestic production and distribution, (iv) providing incentives to manufacturers to produce animal insulin domestically, (v) securing a guarantee from the manufacturer that the drug will be permanently available, (vi) stockpiling the medication to ensure near-term supply; (c) what has Health Canada done or what will it do to ensure that these Canadians receive financial assistance due to high costs as a result of provincial health insurance plans not covering certain medications or treatments; (d) what action has Health Canada taken or will take to ensure (i) that people who suffer negative effects from synthetic insulin are aware of and have access to proper treatment as well as expanded choice in treatment options, (ii) that medical professionals who are responsible for treating Canadians with diabetes are aware of the availability of alternative forms of medication such as beef and pork based insulin; (e) what action has Health Canada taken or will take to ascertain how many Canadians suffer adverse reactions from synthetic insulin; (f) has Health Canada investigated or will be investigating the implementation of a protocol to address this issue, if not, why have steps not been taken to address this issue; and (g) does the lack of the availability of this type of medically necessary treatme ...